AXSM
Axsome Therapeutics
$211.12
+$0.48 (+0.23%)Sep 10, 2026
Key metrics
The numbers that frame AXSM today
- Market cap
- $11.06B
- P/E (TTM)
- -57.7
- EV / FCF
- -152.3
- Gross margin
- 93.2%
- EV / Sales
- 14.1
- ROIC
- -127.7%
- Div yield
- 0%
- Debt / equity
- 2.6
- 52wk Low
- $112.90
- 52wk High
- $260.19
Growth
Revenue and earnings trend for AXSM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AXSM
Is Axsome Therapeutics a good buy?
Hold. Axsome Therapeutics has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Axsome Therapeutics is selling at a high price.
What is the market capitalization of AXSM?
Axsome Therapeutics's market capitalization is $11.06B.
What is the P/E ratio for AXSM stock?
Axsome Therapeutics's current P/E ratio is -57.7.
What is the 52-week high for AXSM stock?
The 52-week high for Axsome Therapeutics is $260.19. The current close of $211.12 is 18.9% below that high.
What is the 52-week low for AXSM stock?
The 52-week low for Axsome Therapeutics is $112.90. The current close of $211.12 is 87% above that low.
Does AXSM stock pay dividends?
Axsome Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AXSM?
Axsome Therapeutics's Debt / Equity ratio is 2.63.